Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1993287695', 'doi': 'https://doi.org/10.1021/jm030091l', 'title': '1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties', 'display_name': '1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties', 'publication_year': 2003, 'publication_date': '2003-05-24', 'ids': {'openalex': 'https://openalex.org/W1993287695', 'doi': 'https://doi.org/10.1021/jm030091l', 'mag': '1993287695', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12801240'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/jm030091l', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S162030435', 'display_name': 'Journal of Medicinal Chemistry', 'issn_l': '0022-2623', 'issn': ['0022-2623', '1520-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5037783763', 'display_name': 'Edwin B. Villhauer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Edwin B. Villhauer', 'raw_affiliation_strings': ['Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936, USA.'], 'affiliations': [{'raw_affiliation_string': 'Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936, USA.', 'institution_ids': ['https://openalex.org/I1283582996']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026745010', 'display_name': 'J. A. Brinkman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210117619', 'display_name': 'Novartis (United States)', 'ror': 'https://ror.org/028fhxy95', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210117619']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John A. Brinkman', 'raw_affiliation_strings': ['Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936'], 'affiliations': [{'raw_affiliation_string': 'Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936', 'institution_ids': ['https://openalex.org/I4210117619']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031894189', 'display_name': 'Goli B. Naderi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210117619', 'display_name': 'Novartis (United States)', 'ror': 'https://ror.org/028fhxy95', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210117619']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Goli B. Naderi', 'raw_affiliation_strings': ['Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936'], 'affiliations': [{'raw_affiliation_string': 'Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936', 'institution_ids': ['https://openalex.org/I4210117619']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074862727', 'display_name': 'Bryan F. Burkey', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210117619', 'display_name': 'Novartis (United States)', 'ror': 'https://ror.org/028fhxy95', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210117619']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bryan F. Burkey', 'raw_affiliation_strings': ['Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936'], 'affiliations': [{'raw_affiliation_string': 'Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936', 'institution_ids': ['https://openalex.org/I4210117619']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030538841', 'display_name': 'Beth E. Dunning', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210117619', 'display_name': 'Novartis (United States)', 'ror': 'https://ror.org/028fhxy95', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210117619']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Beth E. Dunning', 'raw_affiliation_strings': ['Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936'], 'affiliations': [{'raw_affiliation_string': 'Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936', 'institution_ids': ['https://openalex.org/I4210117619']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103415509', 'display_name': 'Kapa Prasad', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210117619', 'display_name': 'Novartis (United States)', 'ror': 'https://ror.org/028fhxy95', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210117619']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kapa Prasad', 'raw_affiliation_strings': ['Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936'], 'affiliations': [{'raw_affiliation_string': 'Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936', 'institution_ids': ['https://openalex.org/I4210117619']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014877911', 'display_name': 'Bonnie L.K. Mangold', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210117619', 'display_name': 'Novartis (United States)', 'ror': 'https://ror.org/028fhxy95', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210117619']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bonnie L. Mangold', 'raw_affiliation_strings': ['Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936'], 'affiliations': [{'raw_affiliation_string': 'Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936', 'institution_ids': ['https://openalex.org/I4210117619']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029015137', 'display_name': 'Mary E. Russell', 'orcid': 'https://orcid.org/0000-0002-5633-0856'}, 'institutions': [{'id': 'https://openalex.org/I4210117619', 'display_name': 'Novartis (United States)', 'ror': 'https://ror.org/028fhxy95', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210117619']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mary E. Russell', 'raw_affiliation_strings': ['Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936'], 'affiliations': [{'raw_affiliation_string': 'Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936', 'institution_ids': ['https://openalex.org/I4210117619']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5101818170', 'display_name': 'Thomas E. Hughes', 'orcid': 'https://orcid.org/0000-0003-0554-427X'}, 'institutions': [{'id': 'https://openalex.org/I4210117619', 'display_name': 'Novartis (United States)', 'ror': 'https://ror.org/028fhxy95', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996', 'https://openalex.org/I4210117619']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Thomas E. Hughes', 'raw_affiliation_strings': ['Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936'], 'affiliations': [{'raw_affiliation_string': 'Novartis Institute for Biomedical Research, One Health Plaza, East Hanover, New Jersey 07936', 'institution_ids': ['https://openalex.org/I4210117619']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 16.473, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 589, 'citation_normalized_percentile': {'value': 0.99991, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '46', 'issue': '13', 'first_page': '2774', 'last_page': '2789'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12505', 'display_name': 'Role of Fibroblast Activation in Cancer Progression', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12505', 'display_name': 'Role of Fibroblast Activation in Cancer Progression', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10401', 'display_name': 'Management of Diabetes Mellitus and Cardiovascular Risk', 'score': 0.9994, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10814', 'display_name': 'Role of Neuropeptides in Physiology and Disease', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pyrrolidine', 'display_name': 'Pyrrolidine', 'score': 0.62241024}, {'id': 'https://openalex.org/keywords/dipeptidyl-peptidase-4-inhibitors', 'display_name': 'Dipeptidyl Peptidase-4 Inhibitors', 'score': 0.550124}, {'id': 'https://openalex.org/keywords/pituitary-adenylate-cyclase-activating-polypeptide', 'display_name': 'Pituitary Adenylate Cyclase-Activating Polypeptide', 'score': 0.508145}, {'id': 'https://openalex.org/keywords/vasoactive-intestinal-peptide', 'display_name': 'Vasoactive Intestinal Peptide', 'score': 0.501524}], 'concepts': [{'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.890039}, {'id': 'https://openalex.org/C181389837', 'wikidata': 'https://www.wikidata.org/wiki/Q461809', 'display_name': 'Bioavailability', 'level': 2, 'score': 0.7047602}, {'id': 'https://openalex.org/C2778851528', 'wikidata': 'https://www.wikidata.org/wiki/Q408898', 'display_name': 'Pyrrolidine', 'level': 2, 'score': 0.62241024}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.54784393}, {'id': 'https://openalex.org/C2777056448', 'wikidata': 'https://www.wikidata.org/wiki/Q285166', 'display_name': 'Oral administration', 'level': 2, 'score': 0.47606915}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.44538608}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.43743813}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.054365754}], 'mesh': [{'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': True}, {'descriptor_ui': 'D018819', 'descriptor_name': 'Dipeptidyl Peptidase 4', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': True}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': True}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': True}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000218', 'descriptor_name': 'Adamantane', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D000284', 'descriptor_name': 'Administration, Oral', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001682', 'descriptor_name': 'Biological Availability', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001786', 'descriptor_name': 'Blood Glucose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001786', 'descriptor_name': 'Blood Glucose', 'qualifier_ui': 'Q000032', 'qualifier_name': 'analysis', 'is_major_topic': False}, {'descriptor_ui': 'D018938', 'descriptor_name': 'Caco-2 Cells', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018360', 'descriptor_name': 'Crystallography, X-Ray', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D018819', 'descriptor_name': 'Dipeptidyl Peptidase 4', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D004791', 'descriptor_name': 'Enzyme Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D008252', 'descriptor_name': 'Macaca fascicularis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D011759', 'descriptor_name': 'Pyrrolidines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011924', 'descriptor_name': 'Rats, Zucker', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013329', 'descriptor_name': 'Structure-Activity Relationship', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/jm030091l', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S162030435', 'display_name': 'Journal of Medicinal Chemistry', 'issn_l': '0022-2623', 'issn': ['0022-2623', '1520-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12801240', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.67, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 48, 'referenced_works': ['https://openalex.org/W1482009781', 'https://openalex.org/W1490344763', 'https://openalex.org/W1534625010', 'https://openalex.org/W1965799612', 'https://openalex.org/W1973351394', 'https://openalex.org/W1973924594', 'https://openalex.org/W1974954480', 'https://openalex.org/W1978902333', 'https://openalex.org/W1978953702', 'https://openalex.org/W1979916078', 'https://openalex.org/W1981001328', 'https://openalex.org/W1985051436', 'https://openalex.org/W1986967657', 'https://openalex.org/W1992966015', 'https://openalex.org/W1996018904', 'https://openalex.org/W2009845088', 'https://openalex.org/W2010922747', 'https://openalex.org/W2031468509', 'https://openalex.org/W2036678616', 'https://openalex.org/W2042845313', 'https://openalex.org/W20437692', 'https://openalex.org/W2054087282', 'https://openalex.org/W2059106217', 'https://openalex.org/W2063693981', 'https://openalex.org/W2064759868', 'https://openalex.org/W2076880341', 'https://openalex.org/W2083684207', 'https://openalex.org/W2084142744', 'https://openalex.org/W2087063469', 'https://openalex.org/W2089437374', 'https://openalex.org/W2099316370', 'https://openalex.org/W2100629874', 'https://openalex.org/W2104763836', 'https://openalex.org/W2109069837', 'https://openalex.org/W2119681138', 'https://openalex.org/W2121894019', 'https://openalex.org/W2141727442', 'https://openalex.org/W2143847100', 'https://openalex.org/W2146232529', 'https://openalex.org/W2148182710', 'https://openalex.org/W2156959752', 'https://openalex.org/W2161075296', 'https://openalex.org/W2162061338', 'https://openalex.org/W2162768091', 'https://openalex.org/W2172204314', 'https://openalex.org/W2324795254', 'https://openalex.org/W2327071073', 'https://openalex.org/W585455371'], 'related_works': ['https://openalex.org/W2437352158', 'https://openalex.org/W2391021644', 'https://openalex.org/W2365953299', 'https://openalex.org/W2314489661', 'https://openalex.org/W2143815486', 'https://openalex.org/W2090573365', 'https://openalex.org/W2086460393', 'https://openalex.org/W2081375274', 'https://openalex.org/W2073311134', 'https://openalex.org/W2022148560'], 'abstract_inverted_index': {'Dipeptidyl': [0], 'peptidase': [1], 'IV': [2], '(DPP-IV)': [3], 'inhibition': [4], 'has': [5], 'the': [6, 34], 'potential': [7, 98], 'to': [8, 45], 'become': [9], 'a': [10, 23, 83], 'valuable': [11], 'therapy': [12], 'for': [13, 99], 'type': [14], '2': [15], 'diabetes.': [16], 'The': [17, 52, 77], 'synthesis': [18], 'and': [19, 69, 93], 'structure-activity': [20], 'relationship': [21], 'of': [22, 55, 67], 'new': [24], 'DPP-IV': [25, 87], 'inhibitor': [26, 88], 'class,': [27], 'N-substituted-glycyl-2-cyanopyrrolidines,': [28], 'are': [29], 'described': [30], 'as': [31, 33], 'well': [32], 'path': [35], 'that': [36, 80], 'led': [37], 'from': [38], 'clinical': [39], 'development': [40], 'compound': [41], '1-[2-[5-cyanopyridin-2-yl)amino]ethylamino]acetyl-2-cyano-(S)-pyrrolidine': [42], '(NVP-DPP728,': [43], '8c)': [44], 'its': [46], 'follow-up,': [47], '1-[[(3-hydroxy-1-adamantyl)': [48], 'amino]acetyl]-2-cyano-(S)-pyrrolidine': [49], '(NVP-LAF237,': [50], '12j).': [51], 'pharmacological': [53], 'profile': [54, 65], '12j': [56, 70, 81], 'in': [57, 71], 'obese': [58], 'Zucker': [59], 'fa/fa': [60], 'rats': [61], 'along': [62], 'with': [63, 97], 'pharmacokinetic': [64], 'comparison': [66], '8c': [68], 'normal': [72], 'cynomolgus': [73], 'monkeys': [74], 'is': [75, 82], 'discussed.': [76], 'results': [78], 'suggest': [79], 'potent,': [84], 'stable,': [85], 'selective': [86], 'possessing': [89], 'excellent': [90], 'oral': [91], 'bioavailability': [92], 'potent': [94], 'antihyperglycemic': [95], 'activity': [96], 'once-a-day': [100], 'administration.': [101]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1993287695', 'counts_by_year': [{'year': 2024, 'cited_by_count': 12}, {'year': 2023, 'cited_by_count': 17}, {'year': 2022, 'cited_by_count': 13}, {'year': 2021, 'cited_by_count': 16}, {'year': 2020, 'cited_by_count': 17}, {'year': 2019, 'cited_by_count': 21}, {'year': 2018, 'cited_by_count': 16}, {'year': 2017, 'cited_by_count': 25}, {'year': 2016, 'cited_by_count': 28}, {'year': 2015, 'cited_by_count': 26}, {'year': 2014, 'cited_by_count': 25}, {'year': 2013, 'cited_by_count': 31}, {'year': 2012, 'cited_by_count': 40}], 'updated_date': '2024-09-19T18:28:31.030135', 'created_date': '2016-06-24'}